Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |